Ramdev's Patanjali Yogpeeth Trust today sought to clarify the controversy over 'Putrajeevak Beej' medicine manufactured by the yoga guru-owned Divya Pharmacy, saying that the drug was meant for dealing with the problem of infertility in women and termed as "false and misleading" the notion that it promises a male child.
The trust in a statement said, "The idea that the medicine helps determine the sex of a child is false and misleading since it is consumed by women and as per science, male chromosomes determine the sex of a child."
The trust argued that the packaging of the medicine does not bear writings suggesting that the drug ensures birth of a male child.
"The packaging mentions that the 'Putrajeevak Beej' helps treating infertility and other related problems in women," the trust said in the statement.
